JD Health International's Profit Jumps 78% in Q1; Share Buyback Proposed
MT Newswires Live
Yesterday
JD Health International (HKG:6618) recorded a 78% rise in attributable profit in the first quarter of 2026 to 1.66 billion yuan from 934.4 million yuan a year prior, according to a Tuesday Hong Kong bourse filing.
The online healthcare platform's revenue for the three months jumped 17% to 19.5 billion yuan from 16.6 billion yuan in the prior-year period.
The firm is also planning to buy back up to $1 billion of shares from the open market over 48 months, pending approval, according to a separate stock exchange filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.